Oak Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Oak Pharma
Largest movements
- Stocks and contracts -€159,910
down €159,910 (-45.4%), from €352,170 to €192,260
- Intangible fixed assets -€99,742
down €99,742 (-56.0%), from €177,992 to €78,250
- Cash -€51,869
down €51,869 (-80.1%), from €64,766 to €12,897
mainly Other debts (-€192,014) and Trade debts (-€132,829)
- Receivables within one year +€24,120
up €24,120 (+15.4%), from €156,888 to €181,007
of which Trade receivables: +€48,166
- Other debts -€192,014
down €192,014 (-46.6%), from €412,014 to €220,000
- Trade debts -€132,829
down €132,829 (-57.3%), from €232,004 to €99,175
- Reserves +€48,250
up €48,250 (+432.6%), from €11,154 to €59,404
- Short-term financial debts -€9,782
down €9,782 (-13.0%), from €75,000 to €65,218
of which Credit institutions: -€25,000
- Gross operating margin +€103,152
up €103,152 (+64.5%), from €159,842 to €262,993
- Depreciation -€35,835
down €35,835 (-55.4%), from €64,739 to €28,904
- Taxes +€14,803
up €14,803 (+801.0%), from €1,848 to €16,652
- Write-downs -€9,736
down €9,736 (-11.9%), from €81,569 to €71,833
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €754,998 | €468,141 | -€286,857 | -38.0% |
| Fixed assets | 21/28 | €177,992 | €78,494 | -€99,497 | -55.9% |
| Intangible fixed assets | 21 | €177,992 | €78,250 | -€99,742 | -56.0% |
| Tangible fixed assets | 22/27 | - | €197 | +€197 | |
| Plant, machinery and equipment | 23 | - | €197 | +€197 | |
| Financial fixed assets | 28 | - | €48 | +€48 | |
| Current assets | 29/58 | €577,007 | €389,647 | -€187,360 | -32.5% |
| Stocks and contracts in progress | 3 | €352,170 | €192,260 | -€159,910 | -45.4% |
| Stocks | 30/36 | €352,170 | €192,260 | -€159,910 | -45.4% |
| Amounts receivable within one year | 40/41 | €156,888 | €181,007 | +€24,120 | +15.4% |
| Trade receivables | 40 | €132,842 | €181,007 | +€48,166 | +36.3% |
| Other amounts receivable | 41 | €24,046 | - | -€24,046 | |
| Cash at bank and in hand | 54/58 | €64,766 | €12,897 | -€51,869 | -80.1% |
| Deferred charges and accrued income | 490/1 | €3,183 | €3,482 | +€300 | +9.4% |
| Total equity and liabilities | 10/49 | €754,998 | €468,141 | -€286,857 | -38.0% |
| Equity | 10/15 | €29,754 | €78,004 | +€48,250 | +162.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €11,154 | €59,404 | +€48,250 | +432.6% |
| Distributable reserves | 133 | €11,154 | €59,404 | +€48,250 | +432.6% |
| Amounts payable | 17/49 | €725,244 | €390,137 | -€335,107 | -46.2% |
| Amounts payable within one year | 42/48 | €720,866 | €386,485 | -€334,381 | -46.4% |
| Financial debts | 43 | €75,000 | €65,218 | -€9,782 | -13.0% |
| Credit institutions | 430/8 | €75,000 | €50,000 | -€25,000 | -33.3% |
| Other loans | 439 | - | €15,218 | +€15,218 | |
| Trade debts | 44 | €232,004 | €99,175 | -€132,829 | -57.3% |
| Suppliers | 440/4 | €232,004 | €99,175 | -€132,829 | -57.3% |
| Taxes, remuneration and social security | 45 | €1,848 | €2,092 | +€244 | +13.2% |
| Taxes | 450/3 | €1,848 | €2,092 | +€244 | +13.2% |
| Other amounts payable | 47/48 | €412,014 | €220,000 | -€192,014 | -46.6% |
| Accrued charges and deferred income | 492/3 | €4,378 | €3,652 | -€726 | -16.6% |
| Remuneration, social security and pensions | 62 | €53 | -€363 | -€417 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €64,739 | €28,904 | -€35,835 | -55.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €81,569 | €71,833 | -€9,736 | -11.9% |
| Other operating charges | 640/8 | €806 | €588 | -€218 | -27.1% |
| Non-recurring operating charges | 66A | - | €90,617 | +€90,617 | |
| Gross operating margin | 9900 | €159,842 | €262,993 | +€103,152 | +64.5% |
| Operating profit (loss) | 9901 | €12,675 | €71,415 | +€58,740 | +463.4% |
| Financial income | 75/76B | €2 | - | -€2 | |
| Recurring financial income | 75 | €2 | - | -€2 | |
| Financial charges | 65/66B | €6,530 | €6,513 | -€16 | -0.2% |
| Recurring financial charges | 65 | €6,530 | €6,513 | -€16 | -0.2% |
| Profit (loss) for the period before taxes | 9903 | €6,147 | €64,902 | +€58,755 | +955.9% |
| Income taxes | 67/77 | €1,848 | €16,652 | +€14,803 | +801.0% |
| Profit (loss) for the period | 9904 | €4,299 | €48,250 | +€43,952 | +1022.5% |
| Profit (loss) for the period to be appropriated | 9905 | €4,299 | €48,250 | +€43,952 | +1022.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.